Acquirer | Target | Price |
---|---|---|
ICU Medical Inc. | Pfizer's global infusion therapy business | $1 billion |
Allergan plc | Worldwide rights to MEDI2070 | $250 million |
Wolters Kluwer, NV | Emmi Solutions | $170 million |
WellCare Health Plans Inc. | Care1st Health Plan Arizona Inc. | $157.5 million |
Accord Healthcare Limited | Actavis Generics assets | $760.4 million |